−Removed: Market for Registrant’s Common Equity, Related Stockholder Matters and Issue Purchases of Equity Securities
+Added: Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our common stock is traded on The Nasdaq Global Select Market under the symbol “STTK”.
−Removed: At February 12, 2024, there were approximately 29 stockholders of record of our common stock.
+Added: At March 17, 2025, there were approximately 23 stockholders of record of our common stock.
Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.
1 unchanged sentence
Use of Proceeds from Initial Public Offering of Common Stock
−Removed: There has been no material change in our intended use of proceeds from our initial public offering (“IPO”) as described in our final prospectus filed with the SEC pursuant to Rule 424(b)(4) on October 13, 2020.
−Removed: Not applicable.
+Added: We completed our initial public offering (“IPO”) on October 14, 2020.
+Added: As a result of the strategic pipeline prioritization and discontinuation of SL-172154, we have changed the “use of proceeds” from the IPO as described in our final prospectus filed with the SEC pursuant to Rule 424(b)(4) on October 13, 2020.
+Added: We currently expect to use our cash, cash equivalents and investments, which include the remaining net proceeds from our IPO, to advance the preclinical and clinical development of our lead product candidate, SL-325, as well as for general corporate purposes.
+Added: Recent Sales of Unregistered Securities
+Added: Issuer Purchases of Equity Securities
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.